Jensen RT (Bethesda, MD, USA). Management of the Zollinger–Ellison syndrome in patients
with multiple endocrine neoplasia type 1 (Minisymposium: MEN & VHL). J Intern Med 1998; …

Mignon M, Cadiot G (Bichat and Claude Bernard Hospital, Paris, France). Diagnostic and
therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine …

The pancreatic component of the multiple endocrine neoplasia type I (MEN I) syndrome is a
difficult and controversial problem because the entire endocrine pancreas is diffusely …

With the development of effective drugs to control the gastric acid hypersecretion in Zollinger-
Ellison syndrome (ZES) patients, the role of surgery has changed. In 1982, Brennan …

Zollinger–Ellison syndrome (ZES) is a clinical syndrome with severe peptic ulcer disease
and diarrhea caused by gastric acid hypersecretion secondary to a neuroendocrine tumour …

Treatment of the Zollinger-Ellison syndrome (ZES) in patients with multiple endocrine
neoplasia type I (MEN I) is controversial. Unlike other patients with ZES who have a single …

Islet cell neoplasia is a frequent occurrence in multiple endocrine neoplasia type 1 (MEN 1).
Sixteen of 27 patients with MEN 1 developed functioning endocrine pancreatic tumor …

The role of surgery in the management of patients with sporadic (not part of multiple
endocrine neoplasia type 1) Zollinger–Ellison syndrome (ZES) is controversial. In this …

In patients with multiple endocrine neoplasia type 1 (MEN-1), gastrinomas are common and
thought to occur predominantly in the pancreas. We describe eight patients with MEN-1 and …

During the three decades since the recognition of the Zollinger‐Ellison syndrome (ZES),
major progress has been made in the diagnosis and treatment of this disease. However, the …